will medicaid cover glp 1 for weight loss now covers GLP-1s obesity in Alabama Patients Face New Barriers for

The table below outlines the exceptional dose-dependent response observed in liver fat reduction and the percentage of patients who successfully cleared their hepatic steatosis (achieving a normal liver fat content of less than 5%) after just 24 weeks of therapy: These unprecedented clearance rates are heavily driven by the glucagon component of the triple agonist, which directly accelerates fatty acid oxidation within the liver (Doggrell, 2023

Pagano, G

The answer to that is emphatically yes

Some women prefer to start small and allow their bodies to adjust slowly before moving to a higher dose, while others choose microdosing as part of their ongoing wellness routine